Companies in #Rare Blood Disorders
Found 2 companies operating in this sector.
Disc Medicine is a clinical-stage biopharmaceutical company developing novel hematology therapeutics for patients with serious and rare blood diseases. The company's pipeline includes bitopertin (a glycine transport-1 inhibitor) for erythropoietic protoporphyria (EPP) and other hematologic disorders.
A biopharmaceutical company focused on discovering and developing peptide-based novel therapeutics for hematology and hematology-related conditions.